OnKure Therapeutics (OKUR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OKUR OnKure Therapeutics

Watchlist

14.760
-0.260-1.73%

Close Nov 27 16:00 ET

196.89MMarket Cap-1553P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

OnKure Therapeutics Reports Strategic Merger and Financial Updates
TipRanksNov 25 22:55 ET
OnKure Therapeutics to Present Preliminary Data From PIKture-01 Trial of OKI-219 at SABCS 2024
Quiver QuantitativeNov 25 17:40 ET
OnKure Announces New Date for Upcoming Investor Call
GlobeNewswireNov 25 17:31 ET
LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Maintains Target Price $31
Moomoo NewsNov 11 07:34 ET · Ratings
Positive Buy Rating for OnKure Therapeutics Driven by Promising OKI-219 Developments
TipRanksNov 11 06:58 ET · Ratings
OnKure Therapeutics Faces Post-Merger Hurdles: Integration Challenges and Talent Competition Threaten Growth
TipRanksNov 9 01:01 ET

Comments

Trytosaveabit

Nov 1 18:57

Watching! Data could serve as a bit of a catalyst?

$OnKure Therapeutics (OKUR.US)$ OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium on December 12th, 2024!

Trytosaveabit

Oct 11 19:11

Check it! Last 2 days! New Form 13’s! Yes PLURAL! Hehehe!

$OnKure Therapeutics (OKUR.US)$ Was it just time to buy? Or? Hehehe
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...